当前蛋白身份:Q96EP0 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
2CT7 Solution Structure of the IBR domain of the RING finger protein 31 protein 提交 2005-05-23 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 779–851(73 aa) 片段:IBR domain
未记录 ZN ZINC ION × 2 SOLUTION NMR
NMR测量条件 pH 7;298 K;离子强度(mmCIF原始值)220;压力 ambient
NMR样品组成 1.55mM IBR domain U-13C,15N; 20mM d-Tris-HCl; 200mM NaCl; 1mM d-DTT; 0.02% NaN3; 0.01mM ZnCl2; 90% H2O, 10% D2O | 90% H2O/10% D2O
分辨率未提供
4DBG Crystal structure of HOIL-1L-UBL complexed with a HOIP-UBA derivative 提交 2012-01-15 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 480–636(157 aa) 片段:Ub-associated domain, residues 480-636
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;15%(w/v) PEG6000, 0.1M KCl, 0.1M HEPES-Na buffer, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K
分辨率 2.71 Å R-free 0.253
4JUY Crystal structure of the PUB domain of E3 ubiquitin ligase RNF31 提交 2013-03-25 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–180(180 aa)
链 B 1–180(180 aa)
未记录 UNX UNKNOWN LIGAND × 40 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;291 K;0.8M K/Na tartrate tetrahydrate, 0.5% PEG MME 5000, 0.1 M BisTris, pH 8.5, vapor diffusion, hanging drop, temperature 291K
分辨率 2.40 Å R-free 0.258
4LJO Structure of an active ligase (HOIP)/ubiquitin transfer complex 提交 2013-07-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 853–1072(220 aa) 片段:E3 ligase HOIP catalytic core (unp residues 853-1072)
未记录 ZN ZINC ION × 5 IMD IMIDAZOLE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.5;293 K;0.1 M carboxylic acids, 0.1 M imidazole, MES, 30 % P550 MME_P20K, pH 6.5, vapour diffusion, temperature 293K, VAPOR DIFFUSION
分辨率 1.56 Å R-free 0.212
4LJP Structure of an active ligase (HOIP-H889A)/ubiquitin transfer complex 提交 2013-07-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 853–1072(220 aa) 片段:E3 ligase HOIP catalytic core (unp residues 853-1072)
突变:H889A ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M amino acids, 0.1 M imidazole, MES, 30 % P550 MME_P20K , pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 2.15 Å R-free 0.216
4LJQ Crystal structure of the catalytic core of E3 ligase HOIP 提交 2013-07-05 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 853–1072(220 aa) 片段:Catalytic domain (unp residues 853-1072)
非标准单体:是(mmCIF未提供具体位点) ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.45 Å R-free 0.243
4LJQ Crystal structure of the catalytic core of E3 ligase HOIP 提交 2013-07-05 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 853–1072(220 aa) 片段:Catalytic domain (unp residues 853-1072)
非标准单体:是(mmCIF未提供具体位点) ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.45 Å R-free 0.243
4LJQ Crystal structure of the catalytic core of E3 ligase HOIP 提交 2013-07-05 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 853–1072(220 aa) 片段:Catalytic domain (unp residues 853-1072)
非标准单体:是(mmCIF未提供具体位点) ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.45 Å R-free 0.243
4LJQ Crystal structure of the catalytic core of E3 ligase HOIP 提交 2013-07-05 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 853–1072(220 aa) 片段:Catalytic domain (unp residues 853-1072)
非标准单体:是(mmCIF未提供具体位点) ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.45 Å R-free 0.243
4LJQ Crystal structure of the catalytic core of E3 ligase HOIP 提交 2013-07-05 Assembly 5 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 853–1072(220 aa) 片段:Catalytic domain (unp residues 853-1072)
链 C 853–1072(220 aa) 片段:Catalytic domain (unp residues 853-1072)
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) ZN ZINC ION × 9 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.45 Å R-free 0.243
4LJQ Crystal structure of the catalytic core of E3 ligase HOIP 提交 2013-07-05 Assembly 6 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 853–1072(220 aa) 片段:Catalytic domain (unp residues 853-1072)
链 D 853–1072(220 aa) 片段:Catalytic domain (unp residues 853-1072)
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) ZN ZINC ION × 9 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;20% PEG 12000, 800 mM LiCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.45 Å R-free 0.243
4OWF Crystal structure of the NEMO CoZi in complex with HOIP NZF1 domain 提交 2014-01-31 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 G 199–228(30 aa)
未记录 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;Co-crystals were obtained after 6 days in 20% (w/v) PEG-3350 and 0.2 M DL-malic acid
分辨率 2.00 Å R-free 0.313
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–184(184 aa)
未记录 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 10 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 J 1–184(184 aa)
未记录 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 11 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 K 1–184(184 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 12 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 L 1–184(184 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 13 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 M 1–184(184 aa)
未记录 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–184(184 aa)
未记录 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–184(184 aa)
未记录 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–184(184 aa)
未记录 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 1–184(184 aa)
未记录 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 F 1–184(184 aa)
未记录 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 7 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 G 1–184(184 aa)
未记录 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 8 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 H 1–184(184 aa)
未记录 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYJ Structure of the apo HOIP PUB domain 提交 2014-02-12 Assembly 9 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 I 1–184(184 aa)
未记录 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;1.3 M ammonium sulphate, 200 mM KI, 100 mM Tris, pH 8.5
分辨率 3.00 Å R-free 0.255
4OYK Structure of HOIP PUB domain bound to OTULIN PIM 提交 2014-02-12 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 3–179(177 aa)
未记录 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.4;295 K;32% PEG 6000, 1M LiCl, 100 mM Tris pH 8.4
分辨率 2.00 Å R-free 0.237
4OYK Structure of HOIP PUB domain bound to OTULIN PIM 提交 2014-02-12 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 3–179(177 aa)
未记录 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.4;295 K;32% PEG 6000, 1M LiCl, 100 mM Tris pH 8.4
分辨率 2.00 Å R-free 0.237
4P09 Crystal structure of HOIP PUB domain 提交 2014-02-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–179(179 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 8.5
分辨率 1.70 Å R-free 0.230
4P0A Crystal structure of HOIP PUB domain in complex with p97 PIM 提交 2014-02-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–179(179 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 6.5
分辨率 2.30 Å R-free 0.249
4P0A Crystal structure of HOIP PUB domain in complex with p97 PIM 提交 2014-02-20 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 1–179(179 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 6.5
分辨率 2.30 Å R-free 0.249
4P0B Crystal structure of HOIP PUB domain in complex with OTULIN PIM 提交 2014-02-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–179(179 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 7.5
分辨率 2.70 Å R-free 0.270
4P0B Crystal structure of HOIP PUB domain in complex with OTULIN PIM 提交 2014-02-20 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 1–179(179 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;0,1M Tris, 20% 2-methyl-2,4-pentanediol, 15% Polyethyleneglycol 3350, pH 7.5
分辨率 2.70 Å R-free 0.270
5EDV Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex 提交 2015-10-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 696–1072(377 aa) 片段:UNP residues 696-1072
未记录 ZN ZINC ION × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2- Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
分辨率 3.48 Å R-free 0.303
5EDV Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex 提交 2015-10-22 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 696–1072(377 aa) 片段:UNP residues 696-1072
链 B 696–1072(377 aa) 片段:UNP residues 696-1072
未记录 ZN ZINC ION × 16 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2- Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
分辨率 3.48 Å R-free 0.303
5EDV Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex 提交 2015-10-22 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 B 696–1072(377 aa) 片段:UNP residues 696-1072
未记录 ZN ZINC ION × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2- Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
分辨率 3.48 Å R-free 0.303
5LJN Structure of the HOIP PUB domain bound to SPATA2 PIM peptide 提交 2016-07-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 5–176(172 aa)
未记录 SO4 SULFATE ION × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;1.7-1.9 M (NH4)2SO4, 50 mM sodium cacodylate pH 6.4-7.0, 15 mM MgCl2 Protein:precipitant ratio; 1:2 200 nl drops
分辨率 2.70 Å R-free 0.281
5LJN Structure of the HOIP PUB domain bound to SPATA2 PIM peptide 提交 2016-07-18 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 5–176(172 aa)
未记录 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;1.7-1.9 M (NH4)2SO4, 50 mM sodium cacodylate pH 6.4-7.0, 15 mM MgCl2 Protein:precipitant ratio; 1:2 200 nl drops
分辨率 2.70 Å R-free 0.281
5X0W Molecular mechanism for the binding between Sharpin and HOIP 提交 2017-01-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 480–639(160 aa) 片段:UNP residues 480-639
非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.3;289 K;0.1 M HEPES (pH 7.3), 7% (w/v) PEG8000, 8% (v/v) ethylene glycerol
分辨率 3.00 Å R-free 0.302
5X0W Molecular mechanism for the binding between Sharpin and HOIP 提交 2017-01-23 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 480–639(160 aa) 片段:UNP residues 480-639
非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.3;289 K;0.1 M HEPES (pH 7.3), 7% (w/v) PEG8000, 8% (v/v) ethylene glycerol
分辨率 3.00 Å R-free 0.302
5X0W Molecular mechanism for the binding between Sharpin and HOIP 提交 2017-01-23 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 480–639(160 aa) 片段:UNP residues 480-639
非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.3;289 K;0.1 M HEPES (pH 7.3), 7% (w/v) PEG8000, 8% (v/v) ethylene glycerol
分辨率 3.00 Å R-free 0.302
5X0W Molecular mechanism for the binding between Sharpin and HOIP 提交 2017-01-23 Assembly 4 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 G 480–639(160 aa) 片段:UNP residues 480-639
非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.3;289 K;0.1 M HEPES (pH 7.3), 7% (w/v) PEG8000, 8% (v/v) ethylene glycerol
分辨率 3.00 Å R-free 0.302
6GZY HOIP-fragment5 complex 提交 2018-07-05 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 853–1072(220 aa)
未记录 FHH methyl 4-[(2-oxidanylidene-1,5,6,7-tetrahydrocyclopenta[b]pyridin-3-yl)carbonylamino]butanoate × 1 ZN ZINC ION × 4 SO4 SULFATE ION × 4 EDO 1,2-ETHANEDIOL × 2 PGE TRIETHYLENE GLYCOL × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;0.1 M Tris HCl pH 8.5, 28% w/v PEG 4000, 0.2 M Li2SO4
分辨率 2.15 Å R-free 0.246
6GZY HOIP-fragment5 complex 提交 2018-07-05 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 853–1072(220 aa)
未记录 FHH methyl 4-[(2-oxidanylidene-1,5,6,7-tetrahydrocyclopenta[b]pyridin-3-yl)carbonylamino]butanoate × 1 ZN ZINC ION × 4 SO4 SULFATE ION × 3 EDO 1,2-ETHANEDIOL × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;0.1 M Tris HCl pH 8.5, 28% w/v PEG 4000, 0.2 M Li2SO4
分辨率 2.15 Å R-free 0.246
6KC5 HOIP-HOIPIN1 complex 提交 2019-06-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 853–1072(220 aa)
未记录 ZN ZINC ION × 4 D5U 2-[3-(2-methoxyphenyl)-3-oxidanylidene-propyl]benzoic acid × 1 GOL GLYCEROL × 4 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;100 mM HEPES-Na (pH 7.5), 200 mM NaCl, 25% PEG 3,350
分辨率 1.54 Å R-free 0.217
6KC6 HOIP-HOIPIN8 complex 提交 2019-06-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 853–1072(220 aa)
未记录 ZN ZINC ION × 4 D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1 CL CHLORIDE ION × 3 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
分辨率 2.12 Å R-free 0.267
6KC6 HOIP-HOIPIN8 complex 提交 2019-06-27 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 853–1072(220 aa)
未记录 ZN ZINC ION × 4 D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1 CL CHLORIDE ION × 1 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
分辨率 2.12 Å R-free 0.267
6KC6 HOIP-HOIPIN8 complex 提交 2019-06-27 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 853–1072(220 aa)
未记录 ZN ZINC ION × 4 D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1 CL CHLORIDE ION × 1 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
分辨率 2.12 Å R-free 0.267
6KC6 HOIP-HOIPIN8 complex 提交 2019-06-27 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 G 853–1072(220 aa)
未记录 ZN ZINC ION × 4 D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1 CL CHLORIDE ION × 1 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
分辨率 2.12 Å R-free 0.267
6KC6 HOIP-HOIPIN8 complex 提交 2019-06-27 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 I 853–1072(220 aa)
未记录 ZN ZINC ION × 4 D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
分辨率 2.12 Å R-free 0.267
6KC6 HOIP-HOIPIN8 complex 提交 2019-06-27 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 K 853–1072(220 aa)
未记录 ZN ZINC ION × 4 D60 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-propyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1 CL CHLORIDE ION × 1 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;200 mM KCl, 20% PEG3,350
分辨率 2.12 Å R-free 0.267
6SC5 dAb3/HOIP-RBR-Ligand2 提交 2019-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 697–1072(376 aa)
未记录 L6B methyl 4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-3-enoate × 1 ZN ZINC ION × 8 SO4 SULFATE ION × 4 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
分辨率 2.10 Å R-free 0.252
6SC6 dAb3/HOIP-RBR apo structure 提交 2019-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 697–1072(376 aa)
未记录 ZN ZINC ION × 8 SO4 SULFATE ION × 5 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
分辨率 2.25 Å R-free 0.246
6SC7 dAb3/HOIP-RBR-Ligand3 提交 2019-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 697–1072(376 aa)
未记录 L6H [2-[3-(cyclooct-4-en-1-yloxycarbonylamino)propylamino]-2-oxidanylidene-ethyl] (~{E})-4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-2-enoate × 1 ZN ZINC ION × 8 SO4 SULFATE ION × 4 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
分辨率 2.56 Å R-free 0.267
6SC8 dAb3/HOIP-RBR-Ligand4 提交 2019-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 697–1072(376 aa)
未记录 L6E [2-(methylamino)-2-oxidanylidene-ethyl] (~{E})-4-[(2-oxidanylidene-5,6,7,8-tetrahydro-1~{H}-quinolin-3-yl)carbonylamino]but-2-enoate × 1 ZN ZINC ION × 8 SO4 SULFATE ION × 3 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
分辨率 2.11 Å R-free 0.261
6SC9 dAb3/HOIP-RBR-HOIPIN-8 提交 2019-07-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 697–1072(376 aa)
未记录 L68 2-[3-[2,6-bis(fluoranyl)-4-(1~{H}-pyrazol-4-yl)phenyl]-3-oxidanylidene-prop-1-enyl]-4-(1-methylpyrazol-4-yl)benzoic acid × 1 ZN ZINC ION × 8 SO4 SULFATE ION × 2 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;Ammonium sulfate, sodium chloride, HEPES
分辨率 2.47 Å R-free 0.252
7TV4 Crystal structure of NEMO CoZi in complex with HOIP NZF1 and linear diubiquitin 提交 2022-02-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 K 350–379(30 aa) 片段:Residues 350-379
未记录 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M Tris-HCl, pH 8.5, 22% v/v PEG Smear Broad
分辨率 4.20 Å R-free 0.286
7UY2 Structure of RNF31 in complex with FP06649, a Helicon Polypeptide 提交 2022-05-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–179(179 aa)
未记录 NH2 AMINO GROUP × 1 WHL N,N'-(1,4-phenylene)diacetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;0.06 M Divalents (0.3M Magnesium chloride hexahydrate; 0.3M Calcium chloride dihydrate), 0.1 M Buffer System 1 (Imidazole; MES monohydrate (acid) pH 6.5), 37.5% Precipitant Mix 4 (25% v/v MPD; 25% PEG 1000; 25% w/v PEG 3350)
分辨率 2.51 Å R-free 0.270
7UY2 Structure of RNF31 in complex with FP06649, a Helicon Polypeptide 提交 2022-05-06 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 1–179(179 aa)
未记录 NH2 AMINO GROUP × 1 WHL N,N'-(1,4-phenylene)diacetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;0.06 M Divalents (0.3M Magnesium chloride hexahydrate; 0.3M Calcium chloride dihydrate), 0.1 M Buffer System 1 (Imidazole; MES monohydrate (acid) pH 6.5), 37.5% Precipitant Mix 4 (25% v/v MPD; 25% PEG 1000; 25% w/v PEG 3350)
分辨率 2.51 Å R-free 0.270
7UYJ Structure of RNF31 in complex with FP06652, a Helicon Polypeptide 提交 2022-05-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–179(179 aa)
未记录 NH2 AMINO GROUP × 1 WHL N,N'-(1,4-phenylene)diacetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;0.1 M Amino Acids (0.2M DL-Glutamic acid monohydrate; 0.2M DL-Alanine; 0.2M Glycine; 0.2M DL-Lysine monohydrochloride; 0.2M DL-Serine),0.1 M Buffer System 1 (Imidazole; MES monohydrate (acid) pH 6.5), 30.0% Precipitant Mix 1 (40% v/v PEG 500* MME; 20 % w/v PEG 20000)
分辨率 2.32 Å R-free 0.274
7UYJ Structure of RNF31 in complex with FP06652, a Helicon Polypeptide 提交 2022-05-06 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 1–179(179 aa)
未记录 NH2 AMINO GROUP × 1 WHL N,N'-(1,4-phenylene)diacetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;0.1 M Amino Acids (0.2M DL-Glutamic acid monohydrate; 0.2M DL-Alanine; 0.2M Glycine; 0.2M DL-Lysine monohydrochloride; 0.2M DL-Serine),0.1 M Buffer System 1 (Imidazole; MES monohydrate (acid) pH 6.5), 30.0% Precipitant Mix 1 (40% v/v PEG 500* MME; 20 % w/v PEG 20000)
分辨率 2.32 Å R-free 0.274
7UYK Structure of RNF31 in complex with FP06655, a Helicon Polypeptide 提交 2022-05-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 480–639(160 aa)
未记录 NH2 AMINO GROUP × 1 WHL N,N'-(1,4-phenylene)diacetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;10% w/v glycerol, 20% w/v ethanol
分辨率 2.70 Å R-free 0.245
7UYK Structure of RNF31 in complex with FP06655, a Helicon Polypeptide 提交 2022-05-06 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 480–639(160 aa)
未记录 NH2 AMINO GROUP × 1 WHL N,N'-(1,4-phenylene)diacetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293.15 K;10% w/v glycerol, 20% w/v ethanol
分辨率 2.70 Å R-free 0.245
7V8F Crystal structure of UBE2L3 bound to HOIP RING1 domain. 提交 2021-08-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 697–793(97 aa)
未记录 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;pH 8;289 K;2%(v/v) 1,4-dioxane, 0.1 M Tris-HCl (pH 8.0), 15%(w/v) PEG 3,350.
分辨率 1.66 Å R-free 0.198
7V8G Crystal structure of HOIP RING1 domain bound to IpaH1.4 LRR domain 提交 2021-08-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 697–793(97 aa)
未记录 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;pH 8;289 K;2%(v/v) 1,4-dioxane, 0.1 M Tris-HCl (pH 8.0), 15%(v/v) PEG 3,350
分辨率 2.75 Å R-free 0.278
7V8G Crystal structure of HOIP RING1 domain bound to IpaH1.4 LRR domain 提交 2021-08-23 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 697–793(97 aa)
未记录 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;pH 8;289 K;2%(v/v) 1,4-dioxane, 0.1 M Tris-HCl (pH 8.0), 15%(v/v) PEG 3,350
分辨率 2.75 Å R-free 0.278
8Z30 Crystal structure of HOIP PUB domain in complex with tolfenamic acid complex 提交 2024-04-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 4–179(176 aa)
链 B 4–179(176 aa)
链 C 4–179(176 aa)
未记录 PEG DI(HYDROXYETHYL)ETHER × 3 TLF 2-[(3-chloro-2-methylphenyl)amino]benzoic acid × 3 PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1 TOE 2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;20 mM Tris, 150 mM NaCl, pH 7.5, 10% w/v PEG1000, 10% w/v PEG8000
分辨率 2.30 Å R-free 0.242
8Z36 Crystal structure of HOIP PUB domain in complex with sertraline complex 提交 2024-04-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 4–179(176 aa)
链 B 4–179(176 aa)
链 C 4–179(176 aa)
未记录 SRE (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;20 mM Na3PO4, 20 mM K3PO4, pH 7.5, 20% PEG 3350
分辨率 2.63 Å R-free 0.269
9AZJ Structure of ubiquitinated NEMO UBAN K285C-Ub G76C bound to HOIP NZF1 提交 2024-03-11 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 9 PDB 声明:nonameric(9) 与蛋白数一致
链 E 351–379(29 aa) 片段:HOIP NZF domain, residues 351-379
链 G 351–379(29 aa) 片段:HOIP NZF domain, residues 351-379
未记录 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 8.6;293 K;150nl protein + 50 nl mother liquor: 0.1 M Tris/Bicine pH 8.6, 24.2% PEG 500 MME, 8% PEG 20K, 0.03 M each of NaI, NaBr, and NaF. Cryoprotected in mother liquor containing 20% glycerol
分辨率 3.32 Å R-free 0.285
9B0B Structure of Optineurin bound to HOIP NZF1 domain 提交 2024-03-11 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 G 350–379(30 aa)
未记录 PGE TRIETHYLENE GLYCOL × 5 PG4 TETRAETHYLENE GLYCOL × 1 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 8.5;293 K;3:1 (protein:mother liquor: 10% PEG 8K, 20% ethylene glycol, 0.1 M Tris/Bicine pH 8.5, 0.03 M MgCl2 and 0.03 M CaCl2. cryoprotected in mother liquor containing 10% glycerol
分辨率 1.70 Å R-free 0.222
9B0B Structure of Optineurin bound to HOIP NZF1 domain 提交 2024-03-11 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 E 350–379(30 aa)
未记录 PGE TRIETHYLENE GLYCOL × 5 PG4 TETRAETHYLENE GLYCOL × 1 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 8.5;293 K;3:1 (protein:mother liquor: 10% PEG 8K, 20% ethylene glycol, 0.1 M Tris/Bicine pH 8.5, 0.03 M MgCl2 and 0.03 M CaCl2. cryoprotected in mother liquor containing 10% glycerol
分辨率 1.70 Å R-free 0.222
9B0Z Structure of Optineurin bound to HOIP NZF1 domain and M1-linked diubiquitin, crystal form 2 提交 2024-03-12 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 7 PDB 声明:heptameric(7) 与蛋白数一致
链 E 350–379(30 aa)
链 F 350–379(30 aa)
未记录 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 8.5;293 K;20% PEG 2K MME, 0.2 M TAO and 0.1 M Tris pH 8.5. Cryoprotected in mother liquor containing 20% glycerol
分辨率 2.41 Å R-free 0.270
9B12 Structure of Optineurin bound to HOIP NZF1 domain and M1-linked diubiquitin, crystal form 1 提交 2024-03-12 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 G 350–379(30 aa)
链 H 350–379(30 aa)
未记录 PG4 TETRAETHYLENE GLYCOL × 1 PGE TRIETHYLENE GLYCOL × 1 CL CHLORIDE ION × 1 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 7.5;293 K;3:1 with reservoir solution containing 50% PEG 200 and 0.1 M HEPES pH 7.5
分辨率 1.81 Å R-free 0.269
9B12 Structure of Optineurin bound to HOIP NZF1 domain and M1-linked diubiquitin, crystal form 1 提交 2024-03-12 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 I 350–379(30 aa)
链 J 350–379(30 aa)
未记录 PG4 TETRAETHYLENE GLYCOL × 1 CL CHLORIDE ION × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 3 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 7.5;293 K;3:1 with reservoir solution containing 50% PEG 200 and 0.1 M HEPES pH 7.5
分辨率 1.81 Å R-free 0.269
9IIC Crystal structure of HOIP RING2-LDD in complex with STK4 KD domain 提交 2024-06-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 857–1071(215 aa) 片段:RING2-LDD
未记录 GOL GLYCEROL × 1 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M Ammonium citrate tribasic (pH 7.0), 20% w/v Polyethylene glycol 3350
分辨率 2.78 Å R-free 0.280
9IIC Crystal structure of HOIP RING2-LDD in complex with STK4 KD domain 提交 2024-06-20 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 857–1071(215 aa) 片段:RING2-LDD
未记录 GOL GLYCEROL × 1 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;289 K;0.2 M Ammonium citrate tribasic (pH 7.0), 20% w/v Polyethylene glycol 3350
分辨率 2.78 Å R-free 0.280